How does lomitapide work?
Lomitapide lowers cholesterol through a different pathway, i.e. through the inhibition of the microsomal triglyceride transfer protein (MTP) (Figure1) 1. MTP is involved in the loading of triglyceride onto apolipoprotein B100, which is a part of the assembly process of very low density lipoprotein (VLDL).
What type of drug is lomitapide?
Lomitapide is in a class of medications called cholesterol-lowering medications. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body.
What class of drug is Juxtapid?
Juxtapid belongs to a class of drugs called Lipid-Lowering Agents, MTP Inhibitor. It is not known if Juxtapid is safe and effective in children.
What is familial dyslipidemia?
Familial hypercholesterolemia (FH) is a diagnosis which refers to individuals with very significantly elevated low-density lipoprotein (LDL) cholesterol (LDL-C) or “bad cholesterol” and an increased risk of early onset of coronary artery disease if not sufficiently treated.
Why is homozygous familial hypercholesterolemia bad?
Homozygous familial hypercholesterolemia is a disorder where it is hard for your body to remove LDL “bad” cholesterol from your blood. The disease raises your chances of a heart attack at an early age, but drugs and other treatments can lower your risk. Cholesterol is waxy stuff that’s in your cells.
Is Nexletol safe?
Nexletol may cause high levels of uric acid in the blood. High levels of uric acid can result in gout (a condition that causes sudden, painful swelling in your joints). Increased levels of uric acid usually occurred within the first 4 weeks after starting Nexletol treatment or taking a placebo.
What are the side effects of Niaspan?
Flushing of the face and neck along with warmth, headache, itching, burning, sweating, chills, or tingling may occur within 2-4 hours of taking this medication. Flushing may persist for a few hours after use. These effects should improve or go away as your body adjusts to the medication.
What is Juxtapid used for?
Juxtapid is a prescription medicine used along with diet and other lipid lowering treatments, including low-density lipoprotein (LDL) apheresis where available, in adults with homozygous familial hypercholesterolemia (HoFH) to reduce LDL (“bad”) cholesterol, total cholesterol, a protein that carries bad cholesterol in …
Is Juxtapid a statin?
Juxtapid is not a statin, and is the first in a new class of medications called microsomal triglyceride transfer protein (MTP) inhibitors.
What causes genetic cholesterol?
Familial hypercholesterolemia is a genetic disorder. It is caused by a defect on chromosome 19. The defect makes the body unable to remove low density lipoprotein (LDL, or bad) cholesterol from the blood. This results in a high level of LDL in the blood.
How is hypercholesterolemia inherited?
Familial hypercholesterolemia is inherited in families in an autosomal dominant manner. In autosomal dominant inherited conditions, a parent who carries an altered gene that causes the condition has a 1 in 2 (50 percent) chance to pass on that altered gene to each of his or her children.
How do you treat homozygous familial hypercholesterolemia?
One option for homozygous familial hypercholesterolemia treatment is apheresis, a treatment which filters cholesterol out of the bloodstream. It’s similar to kidney dialysis and has to be done on a regular basis to be effective. Apheresis is often an out-patient or clinic procedure that takes several hours each time.
How is lomitapide metabolized in the body?
Lomitapide is mainly metabolized by CYP3A4 to it’s inactive metabolites, M1 and M3. CYP enzymes that metabolize lomitapide to a minor extent include CYP 1A2,2B6,2C8,2C19. About 52.9-59.5% is eliminated by the urine and 33.4-35.1% is eliminated by the feces.
What is the generic name for lomitapide?
Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor used in homozygous familial hypercholesterolemia (HoFH) patients. It is marketed under the name Juxtapid (R).
What are the contraindications for lomitapide?
Contraindicated. lomitapide will increase the level or effect of edoxaban by P-glycoprotein (MDR1) efflux transporter. Avoid or Use Alternate Drug. Dose adjustment may be required with strong P-gp inhibitors. DVT/PE treatment: Decrease dose to 30 mg PO once daily.
Does aprepitant increase lomitapide levels?
Increases lomitapide levels several folds. aprepitant increases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Increases lomitapide levels several folds. atazanavir increases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
